SENSEX
NIFTY
GOLD
USD/INR

Weather

image 12    C

Global Business News

The Economic Times

Global Business / The Economic Times

details

Bayer's Asundexian drug reduces stroke risk by 26% in study

Asundexian reduced the chance of another stroke by 26% compared with placebo, when added to standard antiplatelet therapy such as Aspirin, Bayer said Thursday. The data adds to results released in November, and the company plans to submit the findings to regulators for approval.

7 Feb 2026 1:21 am